The Top 5 Analyst Questions From Revvity’s Q2 Earnings Call
Revvity (RVTY) Q2 2026 Earnings Call Transcript
Revvity to Present at Upcoming Investor Conferences
Revvity Launches SuperFlex Prenatal Screening System, Expanding Access to Preeclampsia Testing
Revvity Q2 Earnings Call Highlights
Does Revvity’s Q2 Beat, Higher Guidance and China Exit Alter the Bull Case for RVTY?
Evercore ISI Group Maintains Outperform on Revvity, Raises Price Target to $126
Revvity, Inc. Q2 2026 Earnings Call Summary
Revvity Inc (RVTY) (Q2 2026) Earnings Call Highlights: Strong Diagnostics Growth and Raised ...
Revvity, Inc. 2026 Q2 - Results - Earnings Call Presentation
Revvity, Inc. (RVTY) Q2 2026 Earnings Call Transcript
Revvity (NYSE:RVTY) Beats Q2 EPS Estimates, but Soft Revenue Guidance Caps Stock Reaction
Revvity Tops Second-Quarter Estimates and Lifts Full-Year Outlook
Revvity (RVTY) Q2 Earnings and Revenues Surpass Estimates
Revvity (NYSE:RVTY) Reports Upbeat Q2 CY2026
Revvity Announces Financial Results for the Second Quarter of 2026
Transcript: Revvity Q2 2026 Earnings Conference Call
Revvity Raises FY2026 Adj EPS Guidance from $5.20-$5.30 to $5.30-$5.40 vs $5.27 Est; Raises FY2026 Sales Guidance from $2.810B-$2.840B to $2.830B-$2.860B vs $2.858B Est
Revvity Q2 Adj. EPS $1.41 Beats $1.22 Estimate, Sales $729.688M Beat $709.035M Estimate
Revvity (RVTY) To Report Earnings Tomorrow: Here Is What To Expect
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.